Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study https://www.biorxiv.org/content/10.1101/2023.04.11.536217v1?med=mas
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study https://www.biorxiv.org/content/10.1101/2023.04.11.536217v1?med=mas